BTC.D nears resistance, signaling potential altcoin outperformance ahead. XLM Leads Gains: Stellar Lumens posts a 122% USD ...

Layer-1 blockchain Aptos (APT) has announced a plan to integrate fintech giant Stripe's payment services and the stablecoin ...

If the Senate confirms Bessent, the next person whose signature is on the front of paper U.S. currency will be a fan of ...

Citron said it had hedged its perspective with a short position against MicroStrategy, even though it maintained a positive ...

Bitcoin (BTC) has only a few hundred BTC in sell walls to conquer. At $100K, only 1,000 BTC are available, potentially ...

Bitcoin is nearing $100,000, thanks in part to Donald Trump's re-election. Crypto experts think it's poised to continue, but ...

The FDA has approved a new drug, zanidatamab, for adults with advanced biliary tract cancer, or BTC. Marketed under the brand name Ziihera, it is a first-of-a-kind treatment for patients with ...

The Bitcoin price closed on $100K, but MSTR stock plunged and the Crypto All-Stars presale blasted past $5 million.

Zanidatamab is a bispecific antibody that binds to 2 non-overlapping extracellular epitopes of the HER2 receptor.

Binance traders short Bitcoin, signaling bearish sentiment and potential correction as key levels face increasing pressure.

Gary Gensler is to leave the SEC when Trump moves back into the White House. Coinciding with the news, $BTC is ever closer to ...

BTC price behavior is either hinting at a deeper pullback or an RSI-fueled surge beyond $100,000, Bitcoin market observers ...